GN Store Nord A/S (CPH:GN)
Denmark · Delayed Price · Currency is DKK 106.75
-0.30 (-0.28%)
At close: Dec 30, 2025
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of 15.54 billion as of December 31, 2025. Its market cap has decreased by -22.76% in one year.
Market Cap
15.54B
Enterprise Value
25.77B
Revenue
17.12B
Ranking
n/a
PE Ratio
23.00
Stock Price
106.75
Market Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 330.14M to 15.54B, an increase of 4,608.28%. That is a compound annual growth rate of 12.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 15.54B | -20.19% |
| Dec 30, 2024 | 19.48B | -22.12% |
| Dec 29, 2023 | 25.01B | 22.33% |
| Dec 30, 2022 | 20.44B | -61.08% |
| Dec 30, 2021 | 52.52B | -16.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.45T |
| Genmab | 124.86B |
| Coloplast | 123.14B |
| ALK-Abelló | 50.56B |
| Demant | 45.84B |
| H. Lundbeck | 41.40B |
| Zealand Pharma | 32.85B |
| Ambu A/S | 23.42B |